KR Choksey has come out with its earning estimates on Pharma sector for the quarter ended September 2011. According to the research firm, Ranbaxy September quarter net sales are expected to go up by 8% at Rs 2043
crore, year-on-year, (YoY) basis.
The company's net profit is expected to go up 63% at Rs 117 cr crore on YoY basis.
....more info
crore, year-on-year, (YoY) basis.
The company's net profit is expected to go up 63% at Rs 117 cr crore on YoY basis.
....more info